# Efficacy of Chinese Herbal Medicine Qing Re Huo Xue in Patients With Rheumatoid Arthritis

> **NCT04170504** · PHASE2,PHASE3 · COMPLETED · sponsor: **Guang'anmen Hospital of China Academy of Chinese Medical Sciences** · enrollment: 204 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Qing Re Huo Xue (QRHX) granule
- **DRUG:** Methotrexate
- **DRUG:** Qing Re Huo Xue (QRHX) granule placebo

## Key facts

- **NCT ID:** NCT04170504
- **Lead sponsor:** Guang'anmen Hospital of China Academy of Chinese Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-14
- **Primary completion:** 2022-06-28
- **Final completion:** 2022-06-28
- **Target enrollment:** 204 (ACTUAL)
- **Last updated:** 2024-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04170504

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04170504, "Efficacy of Chinese Herbal Medicine Qing Re Huo Xue in Patients With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04170504. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*